Detalhe da pesquisa
1.
Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: Final results of a multicenter phase II study.
Hepatol Res
; 53(5): 409-416, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36601972
2.
Hepatitis C virus eradication ameliorates the prognosis of advanced hepatocellular carcinoma treated with sorafenib.
J Viral Hepat
; 29(7): 543-550, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35499194
3.
Serum α-fetoprotein level at treatment completion is a useful predictor of hepatocellular carcinoma occurrence more than one year after hepatitis C virus eradication by direct-acting antiviral treatment.
J Viral Hepat
; 29(1): 35-42, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34661320
4.
[A case of multiple osteonecrosis caused by acute-on-chronic pancreatitis].
Nihon Shokakibyo Gakkai Zasshi
; 119(8): 761-767, 2022.
Artigo
em Japonês
| MEDLINE | ID: mdl-35944994
5.
Serum alpha-fetoprotein and clinical outcomes in patients with advanced hepatocellular carcinoma treated with ramucirumab.
Br J Cancer
; 124(8): 1388-1397, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33531690
6.
[A case of pembrolizumab-induced sclerosing cholangitis that was responsive to high-dose steroid therapy].
Nihon Shokakibyo Gakkai Zasshi
; 118(10): 981-990, 2021.
Artigo
em Japonês
| MEDLINE | ID: mdl-34629349
7.
A randomized, double-blind, placebo-controlled, phase 3 study of tivantinib in Japanese patients with MET-high hepatocellular carcinoma.
Cancer Sci
; 111(10): 3759-3769, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32716114
8.
Ramucirumab in elderly patients with hepatocellular carcinoma and elevated alpha-fetoprotein after sorafenib in REACH and REACH-2.
Liver Int
; 40(8): 2008-2020, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32279446
9.
[A case of hepatic toxocariasis in a patient with hepatitis B].
Nihon Shokakibyo Gakkai Zasshi
; 117(3): 270-276, 2020.
Artigo
em Japonês
| MEDLINE | ID: mdl-32161249
10.
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 20(2): 282-296, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30665869
11.
Dynamics of the neutrophiltolymphocyte ratio during lenvatinib treatment for unresectable hepatocellular carcinoma.
Oncol Lett
; 28(1): 309, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38784605
12.
Systemic Chemotherapy for Advanced Hepatocellular Carcinoma in Patients With Child-Pugh class B.
Cancer Diagn Progn
; 4(2): 111-116, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38434920
13.
Neutrophil-to-Lymphocyte Ratio Predicts Immune-related Adverse Events in Patients With Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab.
Cancer Diagn Progn
; 4(1): 34-41, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38173658
14.
Risk factors for loss to follow-up after the start of direct-acting antiviral treatment for hepatitis C virus infection.
JGH Open
; 7(2): 98-104, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36852151
15.
Combined Ultrasound and Computed Tomography Guidance in Radiofrequency Ablation for Hepatocellular Carcinoma Reduces Local Recurrence Rate.
Cancer Diagn Progn
; 3(6): 660-666, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37927810
16.
Potential Predictive Biomarkers of Systemic Drug Therapy for Hepatocellular Carcinoma: Anticipated Usefulness in Clinical Practice.
Cancers (Basel)
; 15(17)2023 Aug 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37686621
17.
FIB4 index and serum αfetoprotein are useful predictors of hepatocellular carcinoma occurrence in hepatitis B patients with nucleos(t)ide analogs therapy.
Exp Ther Med
; 26(3): 441, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37614433
18.
An Imaging Feature Predicts Efficacy of Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma.
Cancer Diagn Progn
; 3(4): 468-474, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37405218
19.
Tumorinfiltrating CD8+ T cells as a biomarker for chemotherapy efficacy in unresectable hepatocellular carcinoma.
Oncol Lett
; 25(6): 259, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37205921
20.
Safety and Effectiveness of Lenvatinib in Patients with Unresectable Hepatocellular Carcinoma in Real-World Clinical Practice: An Observational Post-Marketing Study in Japan.
Drugs Real World Outcomes
; 10(2): 195-205, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36602748